FOTEMUSTINE IN PATIENTS WITH RELAPSING MALIGNANT GLIOMAS - A PHASE-II TRIAL

被引：0
|
作者：
PUNT, CJA
STAMATAKIS, L
GERARD, B
机构：
[1] INST RECH INT SERV,BRUSSELS,BELGIUM
[2] CTR HOSP TIVOLI,LA LOUVIERE,BELGIUM
来源：
ONCOLOGY REPORTS | 1995年 / 2卷 / 02期
关键词：
BRAIN TUMORS; GLIOMA; ASTROCYTOMA; GLIOBLASTOMA MULTIFORME; CHEMOTHERAPY; FOTEMUSTINE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Eleven patients with relapsing malignant glioma were treated with fotemustine chemotherapy, a new nitrosourea derivative. One partial response of 13 months duration occurred, resulting in a marked improvement of the quality of life of the patient. Seven patients had stable disease for a median duration of 5 months. Median survival from inclusion in the study was 6 months. Toxicity was mainly hematologic and manageable. We confirm that fotemustine has some activity in patients with relapsing malignant glioma.
引用
收藏
页码：307 / 308
页数：2
相关论文
共 50 条
  • [21] BEVACIZUMAB IN COMBINATION WITH FOTEMUSTINE AS SALVAGE THERAPY IN RECURRENT ANAPLASTIC GLIOMAS: A PHASE II TRIAL
    Trevisan, E.
    Magistrello, M.
    Bertero, L.
    Bosa, C.
    Crasto, S. Greco
    Garbossa, D.
    Lolli, I.
    Ruda, R.
    Soffietti, R.
    NEURO-ONCOLOGY, 2012, 14 : 50 - 50
  • [22] PHASE-II TRIAL OF CARBOPLATIN IN THE MANAGEMENT OF MALIGNANT MESOTHELIOMA
    RAGHAVAN, D
    GIANOUTSOS, P
    BISHOP, J
    LEE, J
    YOUNG, I
    CORTE, P
    BYE, P
    MCCAUGHAN, B
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) : 151 - 154
  • [23] PHASE-II TRIAL OF TAMOXIFEN IN MALIGNANT-MELANOMA
    LEICHMAN, CG
    SAMSON, MK
    BAKER, LH
    CANCER TREATMENT REPORTS, 1982, 66 (06): : 1447 - 1447
  • [24] PHASE-II TRIAL OF PYRAZOFURIN IN MALIGNANT-MELANOMA
    BUDMAN, D
    CURRIE, V
    WITTES, R
    CANCER TREATMENT REPORTS, 1977, 61 (09): : 1733 - 1734
  • [25] PHASE-II TRIAL OF VINDESINE IN MALIGNANT PLEURAL MESOTHELIOMA
    BOUTIN, C
    IRISSON, M
    GUERIN, JC
    ROEGEL, E
    PARAMELLE, B
    BRAMBILLA, C
    JEANNIN, L
    DABOUIS, G
    LECAER, H
    VIALLAT, JR
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 205 - 206
  • [26] PHASE-II TRIAL OF SPIROGERMANIUM AND VINDESINE IN MALIGNANT GLIOMA
    ALAVI, JB
    SCHOENFELD, D
    SKEEL, RT
    KIRKWOOD, R
    TSUNG, L
    MARSH, JC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 8 - 10
  • [27] CONCURRENT ASSOCIATION OF RADIATION THERAPY AND FOTEMUSTINE FOR NEWLY DIAGNOSED MALIGNANT GLIOMAS, A PHASE II STUDY
    Beauchesne, Patrick D.
    Taillandier, Luc
    Bernier, Valerie
    Carnin, Charlotte
    NEURO-ONCOLOGY, 2009, 11 (06) : 950 - 951
  • [28] PHASE-II TRIAL OF HIGH-DOSE CISPLATIN IN PATIENTS WITH MALIGNANT MESOTHELIOMA
    MINTZER, DM
    KELSEN, D
    FRIMMER, D
    HEELAN, R
    GRALLA, R
    CANCER TREATMENT REPORTS, 1985, 69 (06): : 711 - 712
  • [29] PHASE-II TRIAL OF GALLIUM NITRATE IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA
    CASPER, ES
    STANTON, GF
    SORDILLO, PP
    PARENTE, R
    MICHAELSON, RA
    VINCEGUERRA, V
    CANCER TREATMENT REPORTS, 1985, 69 (09): : 1019 - 1020
  • [30] INTRAVENOUS RECOMBINANT INTERFERON BETA IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS - A PHASE-I PHASE-II STUDY
    YUNG, WKA
    PRADOS, M
    LEVIN, VA
    FETELL, MR
    BENNETT, J
    MAHALEY, MS
    SALCMAN, M
    ETCUBANAS, E
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (11) : 1945 - 1949
12345